Background: The Bethesda category III, AUS/FLUS, comprises a heterogeneous group of thyroid lesions with variable risk of malignancy (ROM). This study evaluates ROM in two subgroups of this category based on nuclear atypia and architectural atypia.
Methods: Cases in Bethesda category III were reported based on nuclear atypia (AUS) and architectural atypia (FLUS).